Univest
Univest
  • Markets
  • Sun Pharma Share Price: 17.4% CAGR in 3 Years as the Sector Heavyweight Faces Cipla and Divi’s Labs

    • November 11, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    Sun Pharma Share Price: 17.4% CAGR in 3 Years as the Sector Heavyweight Faces Cipla and Divi's Labs

    Sun Pharma share price compounded at 17.4% a year over 3 years. See how it compares with Cipla and Divi’s Laboratories on returns and ROE.

    read more
  • Sun Pharma Q2 FY27 Results: Net Profit Falls 36% to Rs 1,989 Crore on Rs 1,269 Crore One-Time Charges, While Adjusted Profit Rises 1.4% and Revenue Climbs 12%

    • November 2, 2026
    • Posted by: Kunal Singla
    • Category: Results
    No Comments
    Sun Pharma Q2 FY27 Results: Net Profit Falls 36% to Rs 1,989 Crore on Rs 1,269 Crore One-Time Charges, While Adjusted Profit Rises 1.4% and Revenue Climbs 12%

    Sun Pharma Q2 results: profit fell 36% to Rs 1,989 crore on one-time charges, but adjusted profit rose 1.4% and revenue 12%. India strong, US weak. Share price and what to watch.

    read more
  • F&O Stocks to Buy: CDSL, Zydus Lifesciences and Sun Pharma on Jay Thakkar’s Near-Term List, With Price Levels, Technicals and Risks

    • October 28, 2026
    • Posted by: Harsh Piplani
    • Category: News
    No Comments
    F&O Stocks to Buy: CDSL, Zydus Lifesciences and Sun Pharma on Jay Thakkar's Near-Term List, With Price Levels, Technicals and Risks

    F&O stocks to buy named by Jay Thakkar: CDSL, Zydus Lifesciences and Sun Pharma. See price levels, technicals, fundamentals and risks, and why range-bound markets matter.

    read more
  • Sun Pharma results Q2FY23

    • November 4, 2022
    • Posted by: Sheen Hitaishi
    • Category: Market
    No Comments
    read more
  • Sun Pharma Q1FY23 Result reports a robust performance

    • August 2, 2022
    • Posted by: Avneet Dhamija
    • Category: Market
    No Comments
    read more